Independent of the effect on growth suppression, which alone has been found to be a weak prognostic marker in many cancers [36], the ACVR2+/TGFBR2- receptor status associated with loss of nuclear p21 points to a pro-metastatic and thus more aggressive cancer phenotype. This evidence concerns the gene CDKN1A and cancer.